Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-week randomized double-blind placebo-controlled varenicline trial in postherpetic neuralgia
2008-002208-24Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing varenicline with placebo (2 arms). Primary endpoint: Change in average weekly pain score (11-point NRS) from baseline to Week 4. Started Jun 2008; status: completed.
02
Drugs
varenicline
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2008-002208-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002208-24.